Johnson & Johnson Cash and Cash Equivalents
Johnson & Johnson (JNJ) had Cash and Cash Equivalents of $20.42 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-23
- 2026-06-28: Cash and Cash Equivalents, at Carrying Value $20.42B.
- 2026-03-29: Cash and Cash Equivalents, at Carrying Value $21.69B.
- 2025-12-28: Cash and Cash Equivalents, at Carrying Value $19.71B.
- 2025-09-28: Cash and Cash Equivalents, at Carrying Value $18.23B.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-28 | $20.42B 10-Q · filed 2026-07-23 | |
| 2026-03-29 | $21.69B 10-Q · filed 2026-04-22 | |
| 2025-12-28 | $19.71B 10-Q · filed 2026-07-23 | |
| 2025-09-28 | $18.23B 10-Q · filed 2025-10-22 | |
| 2025-06-29 | $18.58B 10-Q · filed 2025-07-24 | |
| 2025-03-30 | $38.47B 10-Q · filed 2025-04-23 | |
| 2024-12-29 | $24.11B 10-K · filed 2026-02-11 | |
| 2024-09-29 | $19.98B 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $24.88B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $25.47B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $21.86B 10-K · filed 2025-02-13 | |
| 2023-10-01 | $19.73B 10-Q · filed 2023-10-27 | |
| 2023-07-02 | $21.18B 10-Q · filed 2023-07-31 | |
| 2023-04-02 | $19.17B 10-Q · filed 2023-04-28 | |
| 2023-01-01 | $12.89B 10-K · filed 2024-02-16 | $14.13B 10-K · filed 2023-02-16 |
| 2022-10-02 | $11.36B 10-Q · filed 2022-10-27 | |
| 2022-07-03 | $10.98B 10-Q · filed 2022-07-29 | |
| 2022-04-03 | $10.46B 10-Q · filed 2022-04-29 | |
| 2022-01-02 | $14.49B 10-K · filed 2023-02-16 | |
| 2021-10-03 | $17.60B 10-Q · filed 2021-10-29 | |
| 2021-07-04 | $14.33B 10-Q · filed 2021-07-29 | |
| 2021-04-04 | $12.67B 10-Q · filed 2021-04-30 | |
| 2021-01-03 | $13.98B 10-K · filed 2022-02-17 | |
| 2020-09-27 | $18.96B 10-Q · filed 2020-10-23 | |
| 2020-06-28 | $11.17B 10-Q · filed 2020-07-24 | |
| 2020-03-29 | $15.53B 10-Q · filed 2020-04-29 | |
| 2019-12-29 | $17.30B 10-K · filed 2021-02-22 | |
| 2019-09-29 | $16.25B 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $14.38B 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $14.73B 10-Q · filed 2019-05-01 | |
| 2018-12-30 | $18.11B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $16.06B 10-Q · filed 2018-10-31 | |
| 2018-07-01 | $17.57B 10-Q · filed 2019-07-29 | |
| 2018-04-01 | $14.64B 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $17.82B 10-Q · filed 2019-07-29 | |
| 2017-10-01 | $15.72B 10-Q · filed 2018-10-31 | |
| 2017-07-02 | $12.60B 10-Q · filed 2018-08-02 | |
| 2017-04-02 | $20.91B 10-Q · filed 2018-05-01 | |
| 2017-01-01 | $18.97B 10-K · filed 2019-02-20 | |
| 2016-10-02 | $18.20B 10-Q · filed 2017-11-02 | |
| 2016-07-03 | $18.64B 10-Q · filed 2017-08-03 | |
| 2016-04-03 | $13.86B 10-Q · filed 2017-05-08 | |
| 2016-01-03 | $13.73B 10-K · filed 2019-02-20 | |
| 2015-09-27 | $13.64B 10-Q · filed 2016-11-04 | |
| 2015-06-28 | $10.64B 10-Q · filed 2016-08-04 | |
| 2015-03-29 | $11.99B 10-Q · filed 2016-05-10 | |
| 2014-12-28 | $14.52B 10-K · filed 2018-02-21 | |
| 2014-09-28 | $13.82B 10-Q · filed 2015-10-30 | |
| 2014-06-29 | $14.24B 10-Q · filed 2015-07-31 | |
| 2014-03-30 | $19.72B 10-Q · filed 2015-05-01 | |
| 2013-12-29 | $20.93B 10-K · filed 2017-02-27 | |
| 2013-09-29 | $17.20B 10-Q · filed 2014-10-30 | |
| 2013-06-30 | $17.31B 10-Q · filed 2014-08-01 | |
| 2013-03-31 | $14.86B 10-Q · filed 2014-05-02 | |
| 2012-12-30 | $14.91B 10-K · filed 2016-02-24 | |
| 2012-09-30 | $15.49B 10-Q · filed 2013-11-04 | |
| 2012-07-01 | $14.04B 10-Q · filed 2013-08-01 | |
| 2012-04-01 | $30.27B 10-Q · filed 2013-05-03 | |
| 2012-01-01 | $24.54B 10-K · filed 2015-02-24 | |
| 2011-10-02 | $15.62B 10-Q · filed 2012-11-09 | |
| 2011-07-03 | $14.97B 10-Q · filed 2012-08-02 | |
| 2011-04-03 | $22.36B 10-Q · filed 2012-05-07 | |
| 2011-01-02 | $19.36B 10-K · filed 2014-02-21 | |
| 2010-10-03 | $14.34B 10-Q · filed 2011-11-08 | |
| 2010-07-04 | $12.71B 10-Q · filed 2011-08-09 | |
| 2010-04-04 | $13.74B 10-Q · filed 2011-05-10 | |
| 2010-01-03 | $15.81B 10-K · filed 2013-02-22 | |
| 2009-09-27 | $11.86B 10-Q · filed 2010-11-10 | |
| 2009-06-28 | $11.69B 10-Q · filed 2010-08-11 | |
| 2009-03-29 | $12.59B 10-Q · filed 2010-05-10 | |
| 2008-12-28 | $10.77B 10-K · filed 2012-02-23 | |
| 2008-09-28 | $14.02B 10-Q · filed 2009-11-04 | |
| 2008-06-29 | $12.65B 10-Q · filed 2009-08-04 | |
| 2007-12-30 | $7.77B 10-K · filed 2011-02-25 | |
| 2006-12-31 | $4.08B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |